baber/WOPTO huggingface dataset:
Patent CA-2961506-A1 (CA)
Title: Integrated one-way valve with polyol film
Inventor: BRANYON JACOB DONALD PRUE
IPC: B65D47/32
Filed: 2017-03-21
Abstract: A one-way valve 10 integrated into a lamination 12 of the kind used as a membrane seal for coffee containers and the like. The valve 10 comprises a top layer 14, a substrate 16 and a fluid polyol film 22. The top layer 14 and the substrate 16 are adhered together by an adhesive 18 disposed between the top layer 14 and the substrate 16. The adhesive 18 defines a boundary of a valve chamber 20 in which the top layer 14 and the substrate 16 are not permanently adhered to each other. The film 22 enhances the adhesiveness of the top layer 14 to the substrate 16 in the area of the valve chamber 20 so that gas inside the container does not escape until the internal pressure reaches a minimum value.
Patent CA-2963093-A1 (CA)
Title: Taut inverted catenary mooring system
Inventor: HOOGEVEEN SWANIK MAAS
IPC: B63B22/04
Filed: 2015-10-06
Abstract: A Taut-Inverted-Catenary (TIC) mooring system may be implemented using only field-proven components. The mooring lines yield a positive uplift force on the anchors in all conditions. In the inverted-catenary configuration, geometric stiffness is provided by a subsurface spring buoy or distributed buoyancy elements on the line. The TIC system consists as much as possible of light-weight components, such as polyester fiber rope. Since the uplift force on the anchor is always positive, clearance between polyester rope and the seabed is provided. All geometric stiffness is provided by the spring buoy. Therefore, a ground chain between the seafloor anchor and the fiber rope is not necessary.
Patent CA-2963794-A1 (CA)
Inventor: NARVA KENNETH
IPC: A01H5/00
Filed: 2015-10-07
Abstract: This disclosure concerns nucleic acid molecules and methods of use thereof for control of insect pests through RNA interference-mediated inhibition of target coding and transcribed non-coding sequences in insect pests, including coleopteran and/or hemipteran pests. The disclosure also concerns methods for making transgenic plants that express nucleic acid molecules useful for the control of insect pests, and the plant cells and plants obtained thereby.
Patent CA-2968565-A1 (CA)
Title: Ceramic metal halide lamp
Inventor: SU ROBERT
IPC: H01J9/24
Filed: 2017-05-29
Abstract: A ceramic metal halide lamp includes a luminous tube; an illuminating arrangement having at least two illuminators serially connected with each other and deposed inside the luminous tube; and at least one retainer having at least contacting one end being contacted with an inner surface of the luminous tube to support the illuminators being stability located at a predetermined position inside said luminous tube, wherein the two illuminators are serially connected with each other along a central line of said luminous tube.
Patent CA-2969095-A1 (CA)
Inventor: LEBEAU MICHAEL JAMES
IPC: H04W40/02
Filed: 2014-12-11
Abstract: In one embodiment, a method includes receiving, from a beacon associated with a third-party content provider (e.g., a business), session information of the first user of an online social network. The first user's mobile device may be proximate to and in a wireless communication session with the beacon, which may be located at the third-party content provider. One or more second users, who are each connected to the first user in a social graph, may be selected. A  communication session is not active between the beacon and the mobile devices of the second users. The selection may be based on selected second users being located within a predefined distance of the beacon (e.g., in the same neighborhood). A notification referencing selected second users (e.g., a prompt to invite the selected second users to the beacon location) may be sent to the first user's mobile device.
Patent CA-2969421-A1 (CA)
Inventor: PERNODET NADINE
IPC: A61K8/64
Filed: 2015-11-23
Abstract: Compositions of the invention comprise 8-oxoguanine glycosylase (OGG1) and SIRT6 activating peptide G-A-G-V-S-A-E-NH2. Compositions of the invention exhibit anti-aging effects by promoting the repair of skin cell DNA and/or by protecting skin cell DNA from UV damage.
Patent CA-2969946-A1 (CA)
Title: Metal-modified, plasma-treated thermoplastics for improved electrical performance
Inventor: TSOTSIS THOMAS K
IPC: B32B27/04
Filed: 2017-06-06
Abstract: A method of imparting electrical conductivity on an interlayer material is disclosed. In one non-limiting example the method includes forming the interlayer material from at least one layer of fabric of thermoplastic fibers. The method further includes, treating the surface of the interlayer material using an atmospheric- pressure plasma such that the surface of the interlayer material undergoes a surface activation. Additionally, the method includes depositing a layer of conductive material on the surface of the interlayer material such that the conductive material increases a conductivity of the interlayer material.
Patent CA-2971083-A1 (CA)
Title: Stack of cells of a fuel cell and fuel cell comprising such a stack
Inventor: CERCEAU ARNAUD
IPC: H01M8/241
Filed: 2015-10-02
Abstract: Empilement de cellules de pile à combustible comprenant une plaque anodique et une plaque anodique, à une première de ses deux extrémités, l'empilement est terminé par une première plaque d'extrémité (21) anodique ou respectivement, cathodique, disposée sur la plaque (10, 20) cathodique ou, respectivement, anodique, de la dernière cellule (30) de l'empilement, ladite première plaque d'extrémité (21) délimitant un circuit pour le fluide de refroidissement de la dernière cellule (30) et en ce que cette première plaque d'extrémité (21) est une plaque anodique respectivement cathodique, identique aux plaques (10, 20) anodiques, respectivement cathodiques, des cellules (30) mais étant dépourvue d'orifice de distribution de réactif. Il est ainsi possible de simplifier le développement et le montage d'un empilement de cellules de pile à combustible à membrane échangeuse de protons tout en assurant une bonne étanchéité et un refroidissement satisfaisant à l'extrémité de l'empilement.
Patent CA-2972007-A1 (CA)
Inventor: CHEREWYK BORIS (BRUCE) P
IPC: E21B47/12
Filed: 2017-06-29
Abstract: A system and method are provided for confirming the launch of an actuator for delivery downhole into a wellbore for engagement with a downhole tool such as a packer, sliding sleeve and the like. A wellhead assembly has an axial wellbore in communication with the wellbore. An actuator launcher is located above the wellhead assembly for selectively releasing actuators into the axial wellbore. At least one waypoint is located in the axial bore. A detection device is mounted on the wellhead assembly capable of detecting receipt of a released actuator at the waypoint and generating a confirmation signal in response. A control system receives the confirmation signal, distinguishing between a successful launch and a non-successful launch of the actuator, and producing an output indicating whether introduction of the actuator was successful, the size and material of the actuator, and other pertinent information.
Patent CA-2973139-A1 (CA)
Inventor: FLAX DIRK
IPC: H02P13/00
Filed: 2015-12-18
Abstract: A transformer testing device comprises outputs for detachably connecting the transformer testing device to windings of multiple phases of a transformer.  The transformer testing device further comprises a plurality of sources, each of which is designed to generate a test signal. The transformer testing device also comprises a switching matrix that is connected between the plurality of sources and the outputs.
Patent CA-2973835-A1 (CA)
Title: A dilating device for prostatic urethra
Inventor: BACHAR YEHUDA
IPC: A61F2/04
Filed: 2015-01-26
Abstract: A dilating device for the prostatic urethra comprising: at least three, laterally connected ridges, wherein each ridge is configured to longitudinally engage with a different substantially longitudinal groove of the prostatic urethra of a patient, and wherein the at least three laterally connected ridges are configured to laterally compress to enable insertion into the prostatic urethra in a compressed configuration, and wherein the at least three laterally connected ridges are configured to laterally expand to a normally-open configuration upon deployment within the prostatic urethra, to exert a radially outwards force that dilates the prostatic urethra.
Patent CA-2976966-A1 (CA)
Inventor: HADWIGER PHILIPP
IPC: A61K47/54
Filed: 2011-08-04
Abstract: Abstract Compounds are provided for the delivery of nucleic acids as well as conjugates of these compounds with nucleic acids, in particular siRNAs. A conjugate is prepared by a process comprising conjugating an antisense oligonucleotide with a compound of formula (III):     "cr.? -                                   j (;                          0 _10 0..40 (m) The oligonucleotide is a single-stranded non-naturally occurring nucleic acid comprising a non-naturally occurring nucleotide, which is a locked nucleic acid (LNA). A process for conjugation is also described, in which the conjugating is canied out using N-Hydroxy-succinimide (NHS) chemistry. Date Recue/Date Received 2021-03-23
Patent CA-2977354-A1 (CA)
Inventor: YANAGA HIROKO
IPC: C12N1/00
Filed: 2015-10-26
Abstract: [Problem] To provide a method for serum-free culture of human cartilage cells and a serum-free culture medium. [Solution] A method for serum-free culture of cartilage cells, said method comprising: an enzymatic treatment step for treating a human cartilage cell-containing tissue with a protease; an inhibitor-treatment step for, after the enzymatic treatment step, treating the tissue with an inhibitor for the aforesaid protease; and a culture step for, after the inhibitor-treatment step, culturing the tissue in a serum-free culture medium that contains kartogenin and/or SAG, ITS, FGF2 and hydrocortisone. A serum-free culture medium for culturing cartilage cells, said serum-free culture medium containing kartogenin and/or SAG, ITS, FGF2 and hydrocortisone.
Patent CA-2977817-A1 (CA)
Inventor: DASGUPTA BIPLAB
IPC: A61K31/501
Filed: 2016-03-04
Abstract: Certains modes de réalisation de l'invention comprennent des méthodes pour traiter le cancer chez l'animal par administration d'un inhibiteur de SCD. D'autres modes de réalisation comprennent le traitement du cancer chez des animaux chez lesquels le gène SCD est absent de l'un ou des deux chromatides par administration d'un inhibiteur de SCD. D'autres modes de réalisation additionnels comprennent le traitement du cancer chez des animaux par administration d'un inhibiteur de SCD dans le cas où le gène SCD est absent de l'un ou des deux chromatides et où l'animal a une prise journalière d'une ou de plusieurs de (a) une quantité spécifiée de graisse totale, (b) une quantité spécifiée d'acide gras totaux, (c) une quantité spécifiée d'acides gras mono-insaturés totaux, ou (d) une quantité spécifiée d'acide oléique total. L'invention concerne également des modes de réalisation supplémentaires.
Patent CA-2979296-A1 (CA)
Inventor: BALKEMA-BUSCHMANN ANNE
IPC: C12Q1/6876
Filed: 2017-09-15
Abstract: The present invention provides methods and systems for identify bovine spongiform encephalopathy in cattle, and related uses, agents, and kits. The invention includes and methods for detecting and diagnosing BSE.
Patent CA-2984135-A1 (CA)
Title: Auxotrophes pour proline
Inventor: STUMPE JANA
IPC: C12N1/21
Filed: 2016-05-13
Abstract: La présente invention concerne des compositions et des procédés de fabrication et d'utilisation d'auxotrophes pour proline méthanotrophiques.
Patent CA-2984279-A1 (CA)
Inventor: WISE DAVID
IPC: A61H39/04
Filed: 2017-11-01
Abstract: A trigger point therapy device for applying pressure to a localized area of myofascial tissue that is accessed from the exterior of a patient's body. The therapy device includes a base portion has top and bottom surfaces that define a width dimension for the base portion. The therapy device also includes a pressure applicator that is connected to the base portion. The device allows an equivalent amount of pressure to be applied while the patient is lying on a soft surface as compared to lying on a hard surface. This increases the length of time that a patient will can comfortably use the device and promotes usage of the device by the patient. A method includes placing the device on a soft surface and positioning a patient on the soft surface to place the pressure applicator in engagement with the localized area of myofascial tissue.
Patent CA-2993640-A1 (CA)
Inventor: DIERMEIER DONNA JAN
IPC: A23L29/212
Filed: 2016-06-29
Abstract: A significant amount of yogurt product is used to form a viscoelastic dough capable of being sheeted and cut, without sticking to equipment, and cooked, without over-browning from the high protein and sugar found in yogurt. A number of snack foods can be made with the dough, including a shelf-stable light and crunchy yogurt crisp with whole grain and optional inclusions.
Patent CA-2993926-A1 (CA)
Title: Method for planning the acquisition of images of areas of the earth by a spacecraft
Inventor: BLANC-PAQUES PIERRE
IPC: B64G1/10
Filed: 2016-07-28
Abstract: The invention concerns a method for planning the acquisition of images of areas Z1,...,ZN of the Earth, by a spacecraft on a mission around the Earth, each area Zi of the Earth being associated with a request Ri such that a visual accessibility time interval Ti corresponds to said area Zi. Moreover, the method comprises the steps of: - determining, for each interval Ti, discrete acquisition opportunities for acquiring area Zi such that a start date, a period of execution, a local kinematic constraint and a weight is associated with each of said discrete acquisition opportunities, - grouping together the discrete acquisition opportunities for acquiring areas Zi into a set D, - categorising the discrete acquisition opportunities Di of the set D by ascending start date, - assessing the kinematic compatibility between said discrete acquisition opportunities of set D, - determining an optimal sequence of discrete acquisition opportunities having a maximum weight, and being kinematically compatible.
Patent CA-2994038-A1 (CA)
Inventor: ANTONIONI ANGELO
IPC: F15B15/14
Filed: 2016-08-01
Abstract: A hydraulic actuator (1a, 1b), particularly of the shock absorbing and/or damping type, comprising a piston (2) that is accommodated so that it can slide hermetically in a hollow cylinder (3) so as to divide the internal volume of the hollow cylinder (3) into two chambers (4, 5) mutually separated by the head (6) of the piston (2). The two chambers (4, 5) are connectable separately, respectively by means of at least one delivery duct (17) and at least one discharge duct (18), to a first circuit adapted to feed under pressure a first fluid into one of them with consequent emptying of the other one for the extension or compression movement of the piston (2) with respect to the hollow cylinder (3). The hydraulic actuator comprises a first movable element (7) that is accommodated so that it can slide hermetically in a longitudinal cavity (8) defined inside the stem (9) of the piston (2) so as to divide the longitudinal cavity (8) into two portions (10, 1) with the first one connected to one of the two chambers (4, 5) and with the second one connectable to a second circuit adapted to feed under pressure a second fluid into the second portion (11). The second fluid has a coefficient of compressibility and a nominal pressure greater than those of the first fluid so as to act as a shock absorber and/or damper in case of sudden peaks of pressure in the chamber (4, 5) connected to the first portion (10) of the longitudinal cavity (8) defined inside the stem (9) of the piston (2).
Patent CA-3001233-A1 (CA)
Title: Commande de transitions dans des dispositifs optiquement commutables
Inventor: JACK GORDON
IPC: G02F1/163
Filed: 2016-10-06
Abstract: La présente invention concerne, selon des aspects, des organes de commande et des procédés de commande permettant d'appliquer une tension de commande à des barres omnibus de dispositifs optiquement commutables tels que des dispositifs électrochromiques. De tels dispositifs sont souvent situés sur des fenêtres telles que du verre architectural. Dans certains modes de réalisation, la tension de commande appliquée est commandée d'une manière qui commande efficacement une transition optique sur toute la surface du dispositif électrochromique. La tension de commande est commandée pour tenir compte de différences de la tension efficace appliquée dans des régions entre les barres omnibus et des régions à proximité des barres omnibus. Les régions à proximité des barres omnibus sont soumises à la tension efficace la plus élevée. Dans certains cas, des informations en retour peuvent être utilisées pour surveiller une transition optique. Dans ces cas ou dans d'autres cas, une pluralité de dispositifs optiquement commutables peuvent transiter conjointement pendant une durée particulière pour obtenir des états de teinte approximativement uniforme pendant le temps de la transition.
Patent CA-3001354-A1 (CA)
Inventor: JENKINS J LUKE
IPC: B26D3/16
Filed: 2018-04-13
Abstract: A cutting tool is configured to cut a tube. The cutting tool comprises a tube cutter. The tube cutter includes a housing having a blade opening and a profile defining a tube opening configured to receive the tube. The tube cutter also includes a blade arranged in the blade opening and extending into the tube opening. The cutting tool further comprises a handle having a grip portion and a mounting portion, the mounting portion configured to removably attach the tube cutter to the handle. The cutting tool also comprises a ratcheting mechanism configured to alternatively lock and unlock the tube cutter for rotation with the handle. When the tube cutter is attached to the mounting portion, the tube is arranged in the tube opening, and the handle is rotated in a first direction about the pipe, the ratcheting mechanism locks the tube cutter for rotation with the handle, such that the tube cutter rotates with the handle and the blade cuts the tube. When the tube cutter is attached to the mounting portion, the tube is arranged in the tube opening, and the handle is rotated in a second direction that is opposite the first direction about the pipe, the ratcheting mechanism allows the handle to rotate relative to the tube cutter.
Patent CA-3001744-A1 (CA)
Inventor: MAO LONG
IPC: C07D487/04
Filed: 2016-06-30
Abstract: Provided are methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3 (D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
Patent CA-3002345-A1 (CA)
Title: Composition de soin buccal comprenant du chitosane et de la silice
Inventor: FONTERS JESSIE
IPC: A61K8/25
Filed: 2015-11-20
Abstract: La présente invention concerne des compositions de soin buccal comprenant du chitosane et au moins une silice à petites particules, la composition de soin buccal ayant un pH acide. L'invention concerne en outre des procédés de réduction de la sensibilité dentaire comprenant l'application sur la surface de la dent d'une composition de soin buccal comprenant du chitosane et au moins une silice à petites particules, la composition de soin buccal ayant un pH acide, ainsi que des procédés d'occlusion de tubules de dentine.
Patent CA-3004107-A1 (CA)
Title: Composes glycolipides et leurs utilisations dans le traitement de tumeurs
Inventor: BOVIN NICOLAI VLADIMIROVICH
IPC: A61K31/7032
Filed: 2015-11-11
Abstract: L'invention concerne de nouveaux composés glycolipides et des compositions pharmaceutiques contenant ces glycolipides et des procédés de préparation de ces glycolipides. L'invention concerne également ces glycolipides pour une utilisation dans le traitement de tumeurs et des procédés de traitement de tumeurs utilisant ces glycolipides.
Patent CA-3005304-A1 (CA)
Title: Production de proteines recombinantes n-deglycosylees in vivo par l'expression conjointe avec l'endoglycosidase h
Inventor: MAMMEDOV TARLAN
IPC: C12N9/14
Filed: 2015-11-13
Abstract: Les plantes sont apparues comme un autre système d'expression et sont de plus en plus utilisées, par l'industrie et le milieu universitaire, pour produire des protéines cibles. Toutefois, la capacité des plantes à glycosyler des protéines peut être une limitation importante pour ces protéines, qui ne nécessitent pas de N-glycosylation. Par exemple, les protéines de Plasmodium falciparum, ou la chaîne A du facteur humain XIII ne porte pas de glycanes N-liés, ou l'antigène protecteur (PA) de Bacillus anthracisis n'est pas une glycoprotéine ; toutefois, ces protéines contiennent des sites potentiels de glycosylation N-liés qui peuvent être anormalement glycosylés lors de l'expression chez des systèmes de levure, de mammifère, ou de plante conduisant à des fonctionnalités réduites et à une immunogénicité en raison de repliements modifiés/incorrects et/ou du masquage d'épitopes. Pour résoudre ce problème, nous avons récemment développé une stratégie de déglycosylation enzymatique de protéines in vivo par la co-expression avec la PNGase F bactérienne (Peptide : N-glycosidase F) à l'aide de l'expression transitoire chez des plantes (demande de Brevet WIPO WO/2012/170678), qui permettent la fabrication du vaccin candidat contre la malaria Pfs48/45, pouvant fournir une activité élevée du blocage de la transmission (TB) (Mamedov et al., 2012). En outre, d'autres antigènes déglycosylés induits par des niveaux significativement supérieurs de réponses à des anticorps neutralisant les toxines chez la souris comparativement aux formes glycosylées (Mamedov et al., manuscrit soumis). Bien qu'un traitement par la PNGase F (déglycosylation in vivo) supprime l'oligosaccharide intact, il provoque une modification des acides aminés dans la protéine déglycosylée du fait de la désamidation de l'asparagine (N), dans le site NxS/T (séquence), en un aspartate (D). Dans cette étude, une stratégie a été mise au point pour produire des protéines cibles chez des plantes sous la forme non N-glycosylée, mais sans changement des acides aminés dans le site NxS/T des protéines déglycosylées résultantes, ce qui permet de fournir une production de protéines recombinantes non N-glycosylées chez des plantes ou d'autres systèmes eucaryotes avec un replie de type natif. Ainsi, la présente invention concerne des matériaux et des procédés de déglycosylation in vivo de protéines N-glycosylées recombinantes par co-expression avec la Endo-ß-N-acétylglucosaminidase H (Endo H) chez des plantes, à l'aide d'un système d'expression transitoire. La présente invention concerne également un procédé d'expression de l'activité de l'Endo H chez les plantes.
Patent CA-3005781-A1 (CA)
Title: Compositions comprising bacterial strains
Inventor: MULDER Imke Elisabeth
IPC: A61K35/744
Filed: 2016-11-21
Abstract: The invention provides compositions comprising bacterial strains for treating and preventing cancer.